Texas Attorney General Files Lawsuit Against Tylenol Producers Regarding Autism Assertions

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of acetaminophen, asserting the firms concealed alleged dangers that the pain reliever presented to pediatric neurological development.

This legal action arrives a month after Former President Trump publicized an unverified association between taking acetaminophen - alternatively called acetaminophen - throughout gestation and autism in children.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the only pain reliever suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he stated they "betrayed America by gaining financially from suffering and pushing pills without regard for the potential hazards."

The company states there is insufficient reliable data connecting acetaminophen to autism.

"These companies lied for decades, knowingly endangering millions to increase profits," the attorney general, a Republican, stated.

Kenvue commented that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the likely effects that could have on the well-being of American women and children."

On its official site, Kenvue also mentioned it had "continuously evaluated the applicable studies and there is insufficient valid information that shows a established connection between taking paracetamol and autism."

Organizations representing medical professionals and health professionals agree.

ACOG has declared paracetamol - the main ingredient in Tylenol - is among limited choices for women during pregnancy to address discomfort and elevated temperature, which can create significant medical dangers if left untreated.

"In more than two decades of research on the utilization of paracetamol in pregnancy, not a single reputable study has definitively established that the consumption of paracetamol in any stage of gestation results in neurological conditions in offspring," the organization commented.

The court filing mentions recent announcements from the previous government in claiming the drug is potentially dangerous.

Recently, Trump raised alarms from medical authorities when he advised pregnant women to "fight like hell" not to consume Tylenol when unwell.

Federal regulators then released a statement that medical professionals should consider limiting the use of Tylenol, while also stating that "a direct connection" between the medication and autism spectrum disorder in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had vowed in April to conduct "a massive testing and research effort" that would establish the source of autism in a matter of months.

But authorities advised that finding a unique factor of autism spectrum disorder - thought by researchers to be the consequence of a complex mix of genetic and environmental factors - would not be simple.

Autism is a type of permanent neurological difference and impairment that impacts how individuals encounter and relate to the world, and is recognized using doctors' observations.

In his legal document, the attorney general - a Trump ally who is seeking US Senate - alleges the manufacturer and J&J "intentionally overlooked and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

The lawsuit aims to force the companies "destroy any promotional materials" that claims Tylenol is secure for women during pregnancy.

This legal action parallels the grievances of a assembly of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in recently.

Judicial authorities rejected the legal action, stating research from the plaintiffs' authorities was inconclusive.